A retrospective study performed by Rouzbachman et al. on 33 vulvar and 11 vaginal malignant melanomas identified by next-generation sequencing analysis, found that the most frequent mutations were in C-KIT and NRAS genes, while BRAF mutations were infrequent. The gene discussed is NRAS; the disease is melanoma.